{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T11:44:26Z","timestamp":1698493466978},"reference-count":30,"publisher":"Akademiai Kiado Zrt.","issue":"52","content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2022,12,25]]},"abstract":"<jats:p>A szerz\u0151k egy 50 \u00e9ves myom\u00e1s n\u0151beteget erythrocytosisa miatt vizsg\u00e1ltak. A k\u00e9t\n                    lelet kapcsolat\u00e1t, a myom\u00e1s erythrocytosis gyan\u00faj\u00e1t a v\u00e1rtn\u00e1l magasabb\n                    erythropoetinszint er\u0151s\u00edtette, majd a supravaginalis hysterectomia a diagn\u00f3zist\n                    igazolta. A m\u0171t\u00e9t ut\u00e1n a beteg v\u00e9rk\u00e9pe normaliz\u00e1l\u00f3dott, \u00e9s\n                    sz\u00e9rum-erythropoetinszintje jelent\u0151sen cs\u00f6kkent. Az eset kapcs\u00e1n a szerz\u0151k az\n                    uterusban termel\u0151d\u0151 erythropoetin fiziol\u00f3gi\u00e1j\u00e1r\u00f3l, a sz\u00e9rum-erythropoetinszintek\n                    \u00e9rt\u00e9kel\u00e9s\u00e9r\u0151l \u00e9s differenci\u00e1ldiagnosztikai haszn\u00e1r\u00f3l \u00edrnak. Orv Hetil. 2022;\n                    163(52): 2088\u20132092<\/jats:p>","DOI":"10.1556\/650.2022.32641","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T12:53:01Z","timestamp":1672145581000},"page":"2088-2092","update-policy":"http:\/\/dx.doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":0,"title":["Egy myom\u00e1s erythrocytosis esetr\u0151l \u00e9s a m\u00e9h eredet\u0171 erythropoetin fiziopatol\u00f3gi\u00e1j\u00e1r\u00f3l"],"prefix":"10.1556","volume":"163","author":[{"given":"S\u00e1ndor","family":"Fekete","sequence":"first","affiliation":[{"name":"D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Orsz\u00e1gos Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet, Hematol\u00f3giai \u00e9s \u0150ssejttranszplant\u00e1ci\u00f3s Oszt\u00e1ly Budapest, Albert Fl\u00f3ri\u00e1n \u00fat 5\u20137., 1097 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ron","family":"Somor\u00e1cz","sequence":"additional","affiliation":[{"name":"D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Orsz\u00e1gos Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet, Patol\u00f3giai Oszt\u00e1ly Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Radnai","sequence":"additional","affiliation":[{"name":"D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Orsz\u00e1gos Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet, N\u0151gy\u00f3gy\u00e1szati Oszt\u00e1ly Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Be\u00e1ta","family":"Vilimi","sequence":"additional","affiliation":[{"name":"D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Orsz\u00e1gos Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet, Hematol\u00f3giai \u00e9s \u0150ssejttranszplant\u00e1ci\u00f3s Oszt\u00e1ly Budapest, Albert Fl\u00f3ri\u00e1n \u00fat 5\u20137., 1097 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edit","family":"Babarczi","sequence":"additional","affiliation":[{"name":"D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Orsz\u00e1gos Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet, Patol\u00f3giai Oszt\u00e1ly Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"ref0","unstructured":"1 Gr\u00e1f F, Tak\u00e1csi-Nagy L. Study of the erythropoietin content of plasma and urine by the Gordon H-R method in polycythemia vera. [A plazma \u00e9s a vizelet erythropoietin tartalm\u00e1nak vizsg\u00e1lata Gordon H-R m\u00f3dszer\u00e9vel polycythaemia ver\u00e1ban.] Orv Hetil. 1968; 109: 399-401. [Hungarian]"},{"key":"ref1","unstructured":"2 Gid\u00e1li J, Feh\u00e9r I. Diagnostic value of serum erythropoietin levels. [A sz\u00e9rum eritropoetin szint vizsg\u00e1lat\u00e1nak diagnosztikai jelent\u0151s\u00e9ge.] Orv Hetil. 1999; 140: 411-415. [Hungarian]"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3 Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005; 28: 352: 1779-1790.","DOI":"10.1056\/NEJMoa051113"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4 Andrikovics H, Szilv\u00e1si A, Meggyesi N, et al. Role of the activating mutation Val617Phe of Janus kinase 2 gene in myeloproliferative diseases and significance of its detection. [A 2-es t\u00edpus\u00fa Janus tirozin kin\u00e1z Val617Phe aktiv\u00e1l\u00f3 pontmut\u00e1ci\u00f3 szerepe \u00e9s kimutat\u00e1s\u00e1nak jelent\u0151s\u00e9ge myeloproliferat\u00edv szindr\u00f3m\u00e1ban.] Orv Hetil. 2007; 148: 203-210. [Hungarian]","DOI":"10.1556\/OH.2007.27860"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5 McMullin MF, Harrison CN, Ali S, et al. A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. Br J Haematol. 2019; 184: 176-191. Erratum: Br J Haematol. 2019; 185: 198.","DOI":"10.1111\/bjh.15648"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/0002-9378(57)90528-8","article-title":"Polycythemia associated with uterine myomas","volume":"74","author":"Fleming AR","year":"1957","unstructured":"6 Fleming AR, Markley JC. Polycythemia associated with uterine myomas. Am J Obstet Gynecol. 1957; 74: 677-679.","journal-title":"Am J Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/0029-7844(95)00292-Y","article-title":"The myomatous erythrocytosis syndrome: a review","volume":"86","author":"LevGur M","year":"1995","unstructured":"7 LevGur M, Levie MD. The myomatous erythrocytosis syndrome: a review. Obstet Gynecol. 1995; 86: 1026-1030.","journal-title":"Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","article-title":"Incidence, aetiology and epidemiology of uterine fibroids","volume":"22","author":"8 Okolo","year":"2008","unstructured":"8 Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008; 22: 571-588.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9 Csatl\u00f3s \u00c9, Rig\u00f3 J Jr, Szab\u00f3 I, et al. Uterine leiomyoma. [A m\u00e9h leiomyom\u00e1ja.] Orv Hetil. 2010; 151: 1734-1741. [Hungarian]","DOI":"10.1556\/oh.2010.28977"},{"issue":"6789","key":"ref9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(53)91456-1","article-title":"Polycythaemia with fibroids","volume":"262","author":"Thomson AP","year":"1953","unstructured":"10 Thomson AP, Marson FG. Polycythaemia with fibroids. Lancet 1953; 262 (6789): 759-760.","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11 Mui J, Yang MM, Cohen T, et al. More than a myoma: a review of myomatous erythrocytosis syndrome. J Obstet Gynaecol Can. 2020; 42: 198-203.e3.","DOI":"10.1016\/j.jogc.2018.12.025"},{"key":"ref11","unstructured":"12 Yasuda Y, Fujita Y, Musha T, et al. Expression of erythropoietin in human female reproductive organs. Ital J Anat Embryol. 2001; 106(Suppl 2): 215-222."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13 Chikuma M, Masuda S, Kobayashi T, et al. Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. Am J Physiol Endocrinol Metab. 2000; 279: E1242-E1248.","DOI":"10.1152\/ajpendo.2000.279.6.E1242"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/molehr\/8.5.441","article-title":"Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle","volume":"8","author":"14 Yokomizo","year":"2002","unstructured":"14 Yokomizo R, Matsuzaki S, Uehara S, et al. Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod. 2002; 8: 441-446.","journal-title":"Mol Hum Reprod"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"25381","DOI":"10.1074\/jbc.273.39.25381","article-title":"Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis","volume":"273","author":"15 Yasuda","year":"1998","unstructured":"15 Yasuda Y, Masuda S, Chikuma M, et al. Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem. 1998; 273: 25381-25387.","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1271\/bbb.64.1775","article-title":"Erythropoietin: multiple physiological functions and regulation of biosynthesis","volume":"64","author":"16 Sasaki","year":"2000","unstructured":"16 Sasaki R, Masuda S, Nagao M. Erythropoietin: multiple physiological functions and regulation of biosynthesis. Biosci Biotechnol Biochem. 2000; 64: 1775-1793.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"9174","key":"ref16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0140-6736(99)02273-4","article-title":"Erythrocytosis and a fibroid","volume":"354","author":"17 Yoshida","year":"1999","unstructured":"17 Yoshida M, Koshiyama M, Fujii H, et al. Erythrocytosis and a fibroid. Lancet 1999; 354(9174): 216.","journal-title":"Lancet"},{"key":"ref17","unstructured":"18 Vlasveld LT, de Wit CW, Verweij RA, et al. Myomatous erythrocytosis syndrome: further proof for the pathogenic role of erythropoietin. Neth J Med. 2008; 66: 283-285."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19 Ono Y, Hidaka T, Fukuta K, et al. A case of myomatous erythrocytosis syndrome associated with a large uterine leiomyoma. Case Rep Obstet Gynecol. 2014; 2014: 602139.","DOI":"10.1155\/2014\/602139"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.humpath.2004.10.009","article-title":"Erythropoietin and erythropoietin receptor system in a large uterine myoma of a patient with myomatous erythrocytosis syndrome: possible relationship with the pathogenesis of unusual tumor size","volume":"36","author":"20 Pollio","year":"2005","unstructured":"20 Pollio F, Staibano S, Mansueto G, et al. Erythropoietin and erythropoietin receptor system in a large uterine myoma of a patient with myomatous erythrocytosis syndrome: possible relationship with the pathogenesis of unusual tumor size. Hum Pathol. 2005; 36: 120-127.","journal-title":"Hum Pathol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000074104","article-title":"Erythrocytosis due to an erythropoietin-producing large uterine leiomyoma","volume":"56","author":"21 Yokoyama","year":"2003","unstructured":"21 Yokoyama Y, Shinohara A, Hirokawa M, et al. Erythrocytosis due to an erythropoietin-producing large uterine leiomyoma. Gynecol Obstet Invest. 2003; 56: 179-183.","journal-title":"Gynecol Obstet Invest"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22 Asano R, Asai-Sato M, Miyagi Y, et al. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth. Am J Obstet Gynecol. 2015; 213: 199.e1-e8.","DOI":"10.1016\/j.ajog.2015.02.016"},{"issue":"3692","key":"ref22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1126\/science.150.3692.67","article-title":"Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas","volume":"150","author":"Linder D","year":"1965","unstructured":"23 Linder D, Gartler SM. Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science 1965; 150(3692): 67-69.","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24 Cai YR, Diao XL, Wang SF, et al. X-chromosomal inactivation analysis of uterine leiomyomas reveals a common clonal origin of different tumor nodules in some multiple leiomyomas. Int J Oncol. 2007; 31: 1379-1389.","DOI":"10.3892\/ijo.31.6.1379"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25 Ono M, Bulun SE, Maruyama T. Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma. Biol Reprod. 2014; 91: 149.","DOI":"10.1095\/biolreprod.114.123794"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1055\/s-0035-1558451","article-title":"Uterine leiomyoma stem cells: linking progesterone to growth","volume":"33","author":"26 Bulun","year":"2015","unstructured":"26 Bulun SE, Moravek MB, Yin P, et al. Uterine leiomyoma stem cells: linking progesterone to growth. Semin Reprod Med. 2015; 33: 357-365.","journal-title":"Semin Reprod Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.fertnstert.2018.10.022","article-title":"Growth disparities in uterine leiomyomas associated with MED12 mutation","volume":"111","author":"27 Ferrero","year":"2019","unstructured":"27 Ferrero H. Growth disparities in uterine leiomyomas associated with MED12 mutation. Fertil Steril. 2019; 111: 58-59.","journal-title":"Fertil Steril"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.3390\/ijms20246151","article-title":"Pathogenomics of uterine fibroids development","volume":"20","author":"28 Baranov","year":"2019","unstructured":"28 Baranov VS, Osinovskaya NS, Yarmolinskaya MI. Pathogenomics of uterine fibroids development. Int J Mol Sci. 2019; 20: 6151.","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.fertnstert.2018.09.014","article-title":"Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities","volume":"111","author":"29 Asano","year":"2019","unstructured":"29 Asano R, Asai-Sato M, Matsukuma S, et al. Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities. Fertil Steril. 2019; 111: 178-185.","journal-title":"Fertil Steril"},{"key":"ref29","unstructured":"30 G\u00e1vai M, Hupuczi P, Papp Z. Abdominal myomectomy as an alternative to hysterectomy: analysis of 504 cases. [Abdominalis myomectomia, mint a hysterectomia alternat\u00edv\u00e1ja: 504 eset anal\u00edzise.] Orv Hetil. 2006; 147: 971-978. [Hungarian]"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/52\/article-p2088.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/52\/article-p2088.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/52\/article-p2088.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:06:51Z","timestamp":1698401211000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/52\/article-p2088.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,25]]},"references-count":30,"journal-issue":{"issue":"52"},"URL":"https:\/\/doi.org\/10.1556\/650.2022.32641","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,25]]}}}